Ampicillin (Page 4 of 4)

HOW SUPPLIED

Ampicillin for Injection, USP, is supplied as follows:

NDC Ampicillin for Injection, USP Package Factor
25021-134-10 250 mg per vial 10 vials per carton
25021-135-10 500 mg per vial 10 vials per carton
25021-136-10 1 gram per vial 10 vials per carton
25021-137-20 2 grams per vial 10 vials per carton

Each vial contains ampicillin sodium equivalent to 250 mg, 500 mg, 1 gram or 2 grams ampicillin per vial.

Storage Conditions
Store dry powder at 20˚ to 25˚C (68˚ to 77˚F). [See USP Controlled Room Temperature.]

Sterile, Nonpyrogenic, Preservative-free.
The container closure is not made with natural rubber latex.

Clinitest is a registered trademark of Miles, Inc.
Clinistix is a registered trademark of Bayer Corporation.
Tes-Tape is a registered trademark of Eli Lilly Company.

SAGENT®
Mfd. for SAGENT Pharmaceuticals
Schaumburg, IL 60195 (USA)
Made in Romania©2018 Sagent Pharmaceuticals, Inc.

Revised: April 2018

SAGENT Pharmaceuticals®

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label

NDC 25021-134-10

Rx only

Ampicillin for Injection, USP

250 mg* per vial

For Intravenous or Intramuscular Use

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
(click image for full-size original)

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label

NDC 25021-135-10

Rx only

Ampicillin for Injection, USP

500 mg* per vial

For Intravenous or Intramuscular Use

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
(click image for full-size original)

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label

NDC 25021-136-10

Rx only

Ampicillin for Injection, USP

1 gram* per vial

For Intravenous or Intramuscular Use

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
(click image for full-size original)

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label

NDC 25021-137-20

Rx only

Ampicillin for Injection, USP

2 grams* per vial

For Intravenous Use

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
(click image for full-size original)
AMPICILLIN ampicillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-134
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ampicillin sodium (ampicillin) ampicillin 250 mg
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25021-134-10 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (25021-134-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090354 07/01/2014 04/30/2021
AMPICILLIN ampicillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-135
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ampicillin sodium (ampicillin) ampicillin 500 mg
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25021-135-10 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (25021-135-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090354 07/01/2014 03/31/2022
AMPICILLIN ampicillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-136
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ampicillin sodium (ampicillin) ampicillin 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25021-136-10 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (25021-136-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090354 07/01/2014
AMPICILLIN ampicillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-137
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ampicillin sodium (ampicillin) ampicillin 2 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:25021-137-20 10 VIAL in 1 CARTON contains a VIAL
1 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (25021-137-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090354 07/01/2014
Labeler — Sagent Pharmaceuticals (796852890)

Revised: 05/2021 Sagent Pharmaceuticals

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.